Background: Due to the high rate of recurrence, seborrheic dermatitis (SD) represents a therapeutic problem.
Aim: To evaluate the role of oral itraconazole in the treatment of SD.
Patients And Methods: Thirty-two patients with SD were enrolled in the study.